Pfizer Among 10 Most Profitable Pharma Firms In China
This article was originally published in The Tan Sheet
Sanofi, Roche and Bayer are also ranked among the top 50 companies in profit terms despite foreign drug makers being generally smaller than their Chinese domestic counterparts.
You may also be interested in...
Touting its coronavirus vaccines as a "global public good", China is quietly preparing for the first general approvals and launches, possibly within weeks, developers say. But who will be first in line to receive them? And at what cost? Distribution and pricing are just some of the unanswered questions.
China is set to grant priority reviews to major biologics from Roche, the first CAR-T therapy from Wuxi Juno, and breakthrough therapy designation to a pediatric respiratory antiviral from ArkBio.
China’s National Medical Products Administration has released key regulations and proposals designed to encourage first generics through a 12-month market exclusivity proposal.